Gabrielle Capaldo

The use of biologics to treat psoriasis does not affect antibody production after a patient has had a COVID infection or vaccination, according to a study. In early November 2023, the latest omicron variant JN.1 caused less than 5% of COVID-19 cases in the U.S., according to the Johns Hopkins Bloomberg School of Public Health. As of January 2024, it was estimated to cause more than 60% of cases.

Correcting skin pigmentation, tonality and texture with a combination of chemical peels and neurotoxins may maximize the benefits of both therapies, according to a study.“Chemical peels and neurotoxins have been used cosmetically to improve patient concerns as monotherapies,” Wendy E. Roberts, MD, FAAD, and Nancy Miller, RN, MBA, both of Generational & Cosmetic Dermatology, Rancho

A topical formulation with PATH-3 Technology demonstrated long-term effects and tolerability in the treatment of facial dyschromia, according to a study.“Dyschromia continues to be a challenging cutaneous condition to treat, which has been complicated by the complex pathways involved and the nuances of individual cases,” Jordan V. Wang, MD, MBE, MBA, FAAD, of the Laser & Skin

Using stabilized, super-oxidized hypochlorous acid during and after hair restoration surgery may assist in the healing process, according to a study. “Stabilized, super-oxidized hypochlorous acid (HOCI) is highly effective against bacterial, fungal and viral microorganisms. In addition, topical HOCI will increase tissue oxygenation of wound sites to aid in healing,” Dow Stough, MD, of

Compared with unvaccinated individuals, the recombinant zoster vaccine reduces the 3-year risk for mortality and myocardial infarction among individuals aged 50 to 65 years, according to a study.“Studies report that herpes zoster increases the risk of cardiovascular and cerebrovascular events, including stroke and myocardial infarction,” Matthew F. Helm, MD, of the department of

Vtama cream 1% may be used in combination with an injectable biologic for the treatment of plaque psoriasis, according to a Schweiger Dermatology Group press release. The Psoriasis Treatment Center of New Jersey announced positive results from its single-center, open-label, observational study evaluating Vtama cream 1% (tapinarof, Dermavant Sciences) as an add-on treatment to injectable biologics

While certain demographic factors were associated with a higher risk for paradoxical eczema among patients with psoriasis, treatment with certain biologic classes was not, according to a study.“While biologics targeting tumor necrosis factor (TNF), interleukin (IL)-12/23, IL-17 and IL-23 are highly effective treatments for plaque psoriasis, they are associated with cutaneous adverse events,

The FDA has issued a notification to isotretinoin manufacturers to modify the iPledge Risk Evaluation and Mitigation Strategy to minimize procedural burdens on prescribers, pharmacists and patients. To prevent fetal exposure of isotretinoin, the iPledge Risk Evaluation and Mitigation Strategy (REMS) was implemented as a way to keep prescribers, pharmacists and patients informed about the

Patients with certain autoimmune and inflammatory conditions may develop cutaneous squamous cell carcinoma at higher rates than immunocompetent patients, according to a study. “Data is limited on the risk of skin cancers in different non-organ transplant immunosuppressed patients,” Emily S. Ruiz, MD, MPH, associate professor of dermatology at Harvard Medical School, director of the

Researchers found that early acne education may improve acne health literacy and encourage help-seeking behavior in adolescents, according to a study.Based in Canada, the Acne Education Project is a medical student-led initiative created to increase acne health literacy by providing evidence-based resources to young adolescents aged 9 to 13 years.